Cargando…

γKlotho is a novel marker and cell survival factor in a subset of triple negative breast cancers

Over the last decade, breast cancer mortality has declined. However, triple negative breast cancer (TNBC) remains a challenging problem mostly due to early recurrence and lack of molecularly driven treatments. There is a critical need to identify subgroups of TNBC with common molecular features that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trošt, Nuša, Peña-Llopis, Samuel, Koirala, Sajjan, Stojan, Jurij, Potts, Patrick Ryan, Tacer, Klementina Fon, Martinez, Elisabeth D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823059/ https://www.ncbi.nlm.nih.gov/pubmed/26556877 http://dx.doi.org/10.18632/oncotarget.6006

Ejemplares similares

Correction: γKlotho is a novel marker and cell survival factor in a subset of triple negative breast cancers
por: Trošt, Nuša, et al.
Publicado: (2019)

Nonalcoholic Fatty Liver Disease: Focus on Lipoprotein and Lipid Deregulation
por: Fon Tacer, Klementina, et al.
Publicado: (2011)

Cell-specific secretory granule sorting mechanisms: the role of MAGEL2 and retromer in hypothalamic regulated secretion
por: Štepihar, Denis, et al.
Publicado: (2023)

Hormonal Imbalances in Prader–Willi and Schaaf–Yang Syndromes Imply the Evolution of Specific Regulation of Hypothalamic Neuroendocrine Function in Mammals
por: Hoyos Sanchez, Maria Camila, et al.
Publicado: (2023)

Cumulus Cells Gene Expression Profiling in Terms of Oocyte Maturity in Controlled Ovarian Hyperstimulation Using GnRH Agonist or GnRH Antagonist
por: Devjak, Rok, et al.
Publicado: (2012)

Regulation of Bile Acid Synthesis by Fat-soluble Vitamins A and D
por: Schmidt, Daniel R., et al.
Publicado: (2010)

Serum Klotho as a marker for early diagnosis of acute kidney injury after cardiac surgery
por: Jerin, Aleš, et al.
Publicado: (2020)

The Sterolgene v0 cDNA microarray: a systemic approach to studies of cholesterol homeostasis and drug metabolism
por: Režen, Tadeja, et al.
Publicado: (2008)

Triple negative breast cancer initiating cell subsets differ in functional and molecular characteristics and in γ-secretase inhibitor drug responses
por: Azzam, Diana J, et al.
Publicado: (2013)

γ-Klotho is correlated with resistance to docetaxel in castration-resistant prostate cancer
por: Onishi, Kenta, et al.
Publicado: (2020)

Soluble klotho may be a marker of phosphate reabsorption
por: Tan, Sven-Jean, et al.
Publicado: (2017)

MAGE cancer-testis antigens protect the mammalian germline under environmental stress
por: Fon Tacer, Klementina, et al.
Publicado: (2019)

Predictive and Prognostic Role of Peripheral Blood T-Cell Subsets in Triple-Negative Breast Cancer
por: Li, Meng, et al.
Publicado: (2022)

A Novel Subset of Triple-Negative Breast Cancers with Unique Histology and Immunohistochemical Expression
por: Kalyanasundaram, Swaminathan, et al.
Publicado: (2022)

Motivations for Contributing to Health-Related Articles on Wikipedia: An Interview Study
por: Farič, Nuša, et al.
Publicado: (2014)

Embryo quality predictive models based on cumulus cells gene expression
por: Devjak, R, et al.
Publicado: (2016)

Activation of peroxisome proliferator-activated receptor γ inhibits vascular calcification by upregulating Klotho
por: Cheng, Lijuan, et al.
Publicado: (2017)

Phosphate and Klotho
por: Kuro-o, Makoto
Publicado: (2011)

Phenotypes of Klotho
por: Sen, Jyoti Misra
Publicado: (2019)

Klotho is upregulated in human cardiomyopathy independently of circulating Klotho levels
por: Poelzl, G., et al.
Publicado: (2018)

OR32-2 Alpha Klotho as a Marker of Disease Activity in Acromegaly
por: Schweizer, Junia, et al.
Publicado: (2019)

S-Klotho level and physiological markers of cardiometabolic risk in healthy adult men
por: Żelaźniewicz, Agnieszka, et al.
Publicado: (2022)

Soluble Alpha Klotho in Acromegaly: Comparison With Traditional Markers of Disease Activity
por: Schweizer, Júnia R O L, et al.
Publicado: (2021)

Serum and Urinary Soluble α-Klotho as Markers of Kidney and Vascular Impairment
por: Martín-Vírgala, Julia, et al.
Publicado: (2023)

PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells
por: Byerly, Jessica, et al.
Publicado: (2016)

Expression of the BAD pathway is a marker of triple-negative status and poor outcome
por: Boac, Bernadette M., et al.
Publicado: (2019)

Klotho and the Aging Process
por: Kuro-o, Makoto
Publicado: (2011)

Klotho and Renal Fibrosis
por: Zununi Vahed, Sepide, et al.
Publicado: (2013)

Soluble klotho as a marker of renal fibrosis and podocyte injuries in human kidneys
por: Cho, Nam-Jun, et al.
Publicado: (2018)

An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers
por: Bottai, Giulia, et al.
Publicado: (2016)

Changes in T-cell subsets and clonal repertoire during chemoimmunotherapy with pembrolizumab and paclitaxel or capecitabine for metastatic triple-negative breast cancer
por: Chun, Brie, et al.
Publicado: (2022)

Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer
por: Anurag, Meenakshi, et al.
Publicado: (2022)

Klotho, stem cells, and aging
por: Bian, Ao, et al.
Publicado: (2015)

Klotho protein in neurodegenerative disorders
por: Torbus-Paluszczak, Magdalena, et al.
Publicado: (2018)

Klotho and the Treatment of Human Malignancies
por: Sachdeva, Aishani, et al.
Publicado: (2020)

Klotho, Aging, and the Failing Kidney
por: Buchanan, Sarah, et al.
Publicado: (2020)

Neuroprotective Role of Klotho on Dementia
por: Ananya, Fariha Noor, et al.
Publicado: (2023)

A klotho gene single nucleotide polymorphism is associated with the onset of stroke and plasma klotho concentration
por: Yokoyama, Serina, et al.
Publicado: (2018)

Systemic klotho is associated with KLOTHO variation and predicts intrinsic cortical connectivity in healthy human aging
por: Yokoyama, Jennifer S., et al.
Publicado: (2016)

Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study
por: de la Cruz-Merino, Luis, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c60cdpulipba4t3lijc5jr0js2